Filing Flows

Filing Flows › Centene (CNC) › Q2 2026 › vs Q1 2026

Centene (CNC) Q2 2026 vs Q1 2026 (quarter over quarter)

Centene's revenue rose $3.6B (+7%) from $49.9B in Q1 2026 to $53.6B in Q2 2026. The biggest changes: Medicaid +$3.1B (+11%); Medicare +$731M (+7%); Commercial −$200M (-2%). Gross margin 8.6% against 11.3% (-2.7 pts).

Centene, Q2 2026: revenue $53.6B (+10% year over year), operating margin 2.2%, net earnings $1.1B, operating cash flow $3.6B. The chart draws each line against Q1 2026, the increases inside each band.

Centene: what changed, Q2 2026 vs Q1 2026Centene: what changed, Q2 2026 vs Q1 2026Cost of revenue$4.7BMedicaid$3.1BGross profit−$1.0BOperating cash flow−$776MFree cash flow (OCF − capex)−$750MMedicare$731MOperating profit−$663MPre-tax earnings−$613MNet earnings−$452MOperating expenses−$370M

Margins

Q2 2026Q1 2026Change
Gross margin8.6%11.3%-2.7 pts
Operating margin2.2%3.7%-1.5 pts
Net margin2.0%3.1%-1.1 pts
Free cash flow margin6.4%8.3%-2.0 pts

Every line

LineQ2 2026Q1 2026Change%
Medicaid$32.0B$28.9B$3.1B+11%
Medicare$11.1B$10.3B$731M+7%
Commercial$9.4B$9.6B−$200M-2%
Other$1.2B$1.2B$19.0M+2%
Revenue$53.6B$49.9B$3.6B+7%
Gross profit$4.6B$5.7B−$1.0B-18%
Cost of revenue$49.0B$44.3B$4.7B+11%
Other income, net$288M$238M$50.0M+21%
Operating profit$1.2B$1.9B−$663M-36%
Operating expenses$3.4B$3.8B−$370M-10%
Pre-tax earnings$1.5B$2.1B−$613M-29%
SG&A$3.1B$3.4B−$294M-9%
Other operating costs$316M$392M−$76.0M-19%
Net earnings$1.1B$1.5B−$452M-29%
Income tax$399M$560M−$161M-29%
Depreciation & amortization$300M$300M$00%
Share-based compensation$59.0M$67.0M−$8.0M-12%
Working capital & other$2.1B$2.5B−$316M-13%
Operating cash flow$3.6B$4.4B−$776M-18%
Free cash flow (OCF − capex)$3.4B$4.2B−$750M-18%
Capital expenditures$174M$200M−$26.0M-13%

Questions

How much did Centene's revenue grow quarter over quarter in Q2 2026?

Centene's revenue rose $3.6B (+7%) from $49.9B in Q1 2026 to $53.6B in Q2 2026.

What drove Centene's revenue change in Q2 2026?

Medicaid +$3.1B (+11%); Medicare +$731M (+7%); Commercial −$200M (-2%).

Q2 2026 results → · Compare in the interactive Sankey →